|
|
|
LED Medical Diagnostics Announces Completion of Non-Brokered Private Placement
Posted on
Jun 13, 2013
LED Medical Diagnostics Inc. ("LED" or the "Company") announces that it has completed its previously announced non-brokered private placement of 17,000,000 units at an issue price of $0.15 per unit for gross proceeds of $2.55 million. Each unit is comprised of one common share and one common share purchase warrant with each warrant entitling the holder to acquire one common share at an exercise price of $0.20 for a period of 24 months.
Posted in
Releases
|
New Scientific Review Cites Critical Need for Adjunctive Oral Cancer Screening Devices
Posted on
Feb 6, 2013
BURNABY, British Columbia - January 29, 2013 - LED Medical Diagnostics Inc. (“LED Medical” or “the company”), a developer of LED-based tissue visualization technologies for the medical industry, announced today that a recent scientific review in the highly respected publication, The Journal of the American Dental Association, underscores the need for adjunctive screening technologies to help detect oral cancer and pre-cancer in earlier stages.
Posted in
Releases
|
DenMat Announces Global Distribution of VELscope Vx® Enhanced Oral Assessment System
Posted on
Oct 10, 2012
September 26, 2012
DenMat Announces Global Distribution of VELscope Vx® Enhanced Oral Assessment System
DenMat Holdings, LLC (“DenMat”) is pleased to announce that it has entered into a long-term exclusive agreement with LED Medical Diagnostics, Inc. (“LED”) as the exclusive global distributor (except for a handful of group practices for a limited time) for the VELscope Vx®, including all responsibility for sales and marketing. As the most powerful technology available for assisting in the discovery of oral mucosal abnormalities, VELscope Vx plays a key role in the early discovery of such abnormalities, which can be critically important in the fight against oral cancer.
Posted in
Releases
|
LED Medical Diagnostics Reports 2011 Fourth Quarter and Full-Year Financial Results
Posted on
Apr 3, 2012
Company sees 352% increase in revenues over prior year
BURNABY, British Columbia, April 3, 2012—LED Medical Diagnostics Inc. (TSX-V: LMD) (“LED” or the “Company”) today announced its financial results for the fourth quarter and full year ended December 31, 2011, reported in Canadian dollars and in accordance with International Financial Reporting Standards (“IFRS”). The Company’s results are presented in comparison to the three months and twelve months ended December 31, 2010, also in accordance with IFRS.
Download PDF
Posted in
Releases
|
|
|
|